Unnecessary and accidental use of ADHD drugs increases over 60%, study suggests
{"Image ImageDescription": "Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc, is shown in a Cambridge, Massachusetts pharmacy Thursday, January 19, 2006. Shire Plc, the U.K.'s third-largest drugmaker, said it settled a patent-infringement lawsuit against Impax Laboratories Inc. over its best-selling drug, Adderall XR, used to treat hyperactivity. Photographer: JB Reed/Bloomberg News", "Image Make": "Canon", "Image Model": "Canon EOS 20D", "Image XResolution": "300", "Image YResolution": "300", "Image ResolutionUnit": "Pixels/Inch", "Image Software": "Adobe Photoshop CS Windows", "Image DateTime": "2018-05-18T15:08:33-04:00", "Image Artist": "JB REED", "Image Copyright": "This content is subject to copyright.", "Image ExifOffset": "684", "EXIF ExposureTime": "1/250", "EXIF FNumber": "10", "EXIF ExposureProgram": "Manual", "EXIF ISOSpeedRatings": "1600", "EXIF ExifVersion": "0220", "EXIF DateTimeOriginal": "2006:01:19 20:12:01", "EXIF ShutterSpeedValue": "995723/125000", "EXIF ApertureValue": "415241/62500", "EXIF ExposureBiasValue": "0", "EXIF MeteringMode": "Partial", "EXIF Flash": "Flash fired, compulsory flash mode", "EXIF FocalLength": "70", "EXIF ExifImageWidth": "3000", "EXIF ExifImageLength": "1687"}